Vemlidy

Active Ingredient(s): Tenofovir Alafenamide
FDA Approved: * November 10, 2016
Pharm Company: * GILEAD SCIENCES INC
Category: Hepatitis

Tenofovir alafenamide, sold under the brand name Vemlidy, is a hepatitis B virus (HBV) nucleotide reverse transcriptase inhibitor medication for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease.[3] It is taken by mouth.[3] Tenofovir alafenamide is a prodrug of tenofovir. It was developed by Gilead Sciences based on the protide technology of Chris McGuigan for use in the treatment of HIV/AIDS and chronic hepatit... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vemlidy 25 mg Oral Tablet
NDC: 61958-2301
Labeler:
Gilead Sciences, Inc.

Related Brands

Drugs with the same active ingredients